24 days
Time to First Decision

Uro, Volume 3, Issue 4

2023 December - 4 articles

Cover Story: The management of penile cancer patients has its grey zones. In particular, no strong evidence or recommendations exist regarding the timing of prophylactic lymphadenectomy. Here, we aim to review the impact that the timing of inguinal and pelvic prophylactic lymph node dissection has on patient outcomes. Four clinical trials, all focusing on the role of inguinal lymph node dissection, are included. Despite the lack of randomized and controlled trials, this review suggests that lymph node dissection should be performed as soon as possible after diagnosis, with 3 months suggested as a realistic cut-off. The survival of penile cancer patients is strictly related to the timing of prophylactic pelvic lymph node dissection. All patients at high risk of nodal metastasis should be offered lymph node dissection within three months of diagnosis until new prediction tools are validated. View this paper

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (4)

Select all

Article

8 Citations

4,525 Views

11 Pages

Understanding Renal Failure Mortality Trends and Determinants in the US (1999–2020): Impacts of the Affordable Care Act, Advancements, Disparities, and Challenges

Oscar Salichs,
Sishir Doddi,
Taryn Hibshman,
Jama Hersi and
Puneet Sindhwani

Uro2023, 3(4), 271-281;https://doi.org/10.3390/uro3040027

18 December 2023

Introduction: Renal failure, encompassing both acute and chronic forms, stands as a formidable public health challenge with far-reaching consequences for individual well-being and healthcare systems. This study delves into the mortality rates of rena...

Full Article

Brief Report

1 Citations

12,412 Views

9 Pages

Efficacy of Fosfomycin against Extended Spectrum Beta-Lactamase-Producing Escherichia coli Isolated from Patient Urinary Cultures in the General Reference Hospital of Niamey, Niger

Alassane Halawen Mohamed,
René Dembélé,
Alio Mahamadou Fody,
Alix Bénédicte Kagambèga,
Hiliassa Coulibaly,
Frédéric François Bado,
Chaibou Salaou,
Laouali Boubou,
Alkassoum Ibrahim and
Nicolas Barro
+ 1 author

Uro2023, 3(4), 262-270;https://doi.org/10.3390/uro3040026

4 December 2023

Urinary tract infection (UTI) is a common patient infection and a major public health problem today. The rapid spread of antibiotic resistance genes in Enterobacterales, particularly in Extended-spectrum beta-lactamases producing Escherichia coli (ES...

Full Article

Review

2 Citations

3,392 Views

11 Pages

Prophylactic Lymphadenectomy in Patients with Penile Cancer: Is Sooner Better?

Tommaso Cai,
Marco Capece,
Maria Grazia Zorzi,
Alessandro Palmieri,
Gabriella Nesi,
Mattia Barbareschi and
Truls E. Bjerklund Johansen

Uro2023, 3(4), 251-261;https://doi.org/10.3390/uro3040025

9 November 2023

Background: Management of penile cancer patients has its grey zones. In particular, no strong evidence or recommendations exist regarding the timing of prophylactic lymphadenectomy. Here, we aim to review the impact that the timing of inguinal and pe...

Full Article

Feature Paper
Review

2 Citations

7,037 Views

12 Pages

Fertility Preservation Options for Transgender Patients: An Overview

Natalie Mainland,
Dana A. Ohl,
Ahmed R. Assaly,
Nabila Azeem,
Amber Cooper,
Angie Beltsos,
Puneet Sindhwani and
Tariq A. Shah

Uro2023, 3(4), 239-250;https://doi.org/10.3390/uro3040024

8 October 2023

Fertility preservation technologies have existed for decades, and the field is rapidly advancing; limited data exist regarding the use of these technologies by transgender patients. Many options are available for transgender patients who wish to pres...

Full Article

Get Alerted

Add your email address to receive forthcoming issues of this journal.

Uro - ISSN 2673-4397

Imprint

Download Flyer